Multicenter, prospective and open-label clinical trial to evaluate the viability, performance and safety of ex vivo normothermic perfusion in kidney transplantation from DCD and DBD donors.
Recruiting now
A multicenter, prospective and open-label clinical investigation to evaluate the viability, performance and safety of ex vivo normothermic perfusion in kidney transplantation from DCD and DBD donors.
Sponsor: Ebers Medical Technology, S.L.
Last updated Sep 10, 2026 16:00 UTC